| Members |
targetComponentId |
| Anti-criminal psychotherapy NOS (regime/therapy) |
Anti-criminal psychotherapy NOS |
| Anti-criminal psychotherapy NOS |
Anti-criminal psychotherapy NOS (regime/therapy) |
| Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
| Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
| Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
| Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
| Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
| Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
| Anti-gliadin antibody level |
Gliadin antibody measurement |
| Anti-gliadin IgA antibody level |
Gliadin antibody, IgA measurement |
| Anti-gliadin IgG antibody level |
Gliadin antibody, IgG measurement |
| Anti-hemoglobin antibody level |
Anti-haemoglobin antibody measurement |
| Anti-hepatitis B immunoglobulin given |
immunoglobuline anti-hépatite B administrée |
| Anti-hyaluronidase |
Hyaluronidase antibody |
| Anti-inflammat. light therapy |
Light therapy for inflammation (procedure) |
| Anti-inflammatory agent (product) |
agent anti-inflammatoire |
| Anti-inflammatory agent (substance) |
agent anti-inflammatoire |
| Anti-liver-kidney microsomal antibody level |
Measurement of liver and kidney microsomal antibody (procedure) |
| Anti-myocardium antibody |
Cardiac muscle antibody (substance) |
| Anti-neutrophil cytoplasmic antibody level |
Antineutrophil cytoplasmic antibody measurement |
| Anti-neutrophil cytoplasmic antibody negative |
Anti-neutrophil cytoplasmic antibody negative |
| Anti-nuclear IgG antibody level |
Anti-nuclear IgG antibody level |
| Anti-nuclear IgG antibody level |
Anti-nuclear IgG antibody level |
| Anti-nuclear IgM antibody level |
Anti-nuclear IgM antibody level |
| Anti-nuclear IgM antibody level |
Anti-nuclear IgM antibody level |
| Anti-nuclear factor level (procedure) |
Antinuclear antibody measurement (procedure) |
| Anti-nuclear factor level |
Antinuclear antibody measurement (procedure) |
| Anti-nuclear factor level |
Antinuclear antibody measurement (procedure) |
| Anti-nuclear factor weakly positive |
Anti-nuclear factor weakly positive |
| Anti-nuclear: ([factor] or [antibody] & level) |
Antinuclear antibody |
| Anti-phosphatidylglycerol antibody |
Phosphatidyl glycerol antibody (substance) |
| Anti-rabies immunoglobulin injection |
Anti-rabies immunoglobulin injection |
| Anti-staph. hemolysin titer |
Anti-staphylococcal haemolysin titre measurement |
| Anti-streptokinase |
Streptokinase antibody |
| Anti-suicide psychotherapy |
Anti-suicide psychotherapy (regime/therapy) |
| Anti-suicide psychotherapy NOS |
Anti-suicide psychotherapy NOS (regime/therapy) |
| Anti-suicide psychotherapy NOS (regime/therapy) |
Anti-suicide psychotherapy NOS |
| Anti-testes antibody level (procedure) |
Measurement of testis antibody (procedure) |
| Anti-tissue transglutaminase level (procedure) |
Anti-tissue transglutaminase level |
| Anti-tissue transglutaminase level (procedure) |
Anti-tissue transglutaminase level |
| Anti-tuberculous drug reaction |
Antituberculous drug adverse reaction |
| Anti-tuberculous drug reaction |
Antituberculous drug adverse reaction |
| Anti-varic-Zoster immunoglob (& injection) |
VarIg varicella immunoglobulin unspecified |
| Anti-varicella-zoster ig injection (product) |
VarIg varicella immunoglobulin unspecified |
| Antianemia agent (substance) |
hématinique |
| Antianginal therapy (procedure) |
Antianginal therapy |
| Antianginal therapy |
Antianginal therapy |
| Antibacterial drugs (substance) |
médicament antibactérien |
| Antibiotic antifungal adverse reaction |
Antifungal drug adverse reaction |
| Antibiotic antituberculosis drug |
Medicinal product acting as antitubercular agent (product) |
| Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis not recommended |
| Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis not recommended |
| Antibiotic prophylaxis recommended |
Antibiotic prophylaxis recommended |
| Antibiotic prophylaxis recommended |
Antibiotic prophylaxis recommended |
| Antibody class (substance) |
Immunoglobulin isotype |
| Antibody constant region |
Immunoglobulin, constant region |
| Antibody hypervariable region |
Immunoglobulin, hypervariable region |
| Antibody studies |
Antibody studies |
| Antibody titer raized [D] |
Antibody titre above reference range |
| Antibody to SCL-70 |
Topoisomerase-1 antibody |
| Antibody to extractable nuclear antigen typing (finding) |
Antibody to extractable nuclear antigen measurement |
| Antibody to extractable nuclear antigen typing |
Antibody to extractable nuclear antigen measurement |
| Antibody to extractable nuclear antigen typing |
Antibody to extractable nuclear antigen measurement |
| Antibody to nuclear RNP measurement |
RNP antibody measurement |
| Antibody to ribosomal RNP measurement (procedure) |
RNP antibody measurement |
| Antibody variable region |
Immunoglobulin, variable region |
| Immunoglobulin A (IgA) antibody |
Immunoglobulin A (substance) |
| Immunoglobulin D (IgD) antibody |
Immunoglobulin D |
| Immunoglobulin E (IgE) antibody |
Immunoglobulin E |
| Immunoglobulin G (IgG) antibody |
Immunoglobulin G (substance) |
| Immunoglobulin M (IgM) antibody |
Immunoglobulin M (substance) |
| Anticholinergic premedications (product) |
Product containing acetylcholine receptor antagonist (product) |
| Anticholinesterase overdose of undetermined intent |
Anticholinesterase overdose |
| Anticholinesterase poisoning of undetermined intent |
Poisoning by anticholinesterase |
| Anticoagulant therapy |
Anticoagulant therapy |
| Anticonvulsive therapy |
Anticonvulsant therapy |
| Antidepressant drug (substance) |
Medicinal product acting as antidepressant agent (product) |
| Antidiabetic agent (product) |
préparation antidiabétique |
| Antidiarrheal adsorbent mixture (product) |
agent antidiarrhéique |
| Antidiarrheal antimotility drugs (product) |
agent antidiarrhéique |
| Antidiarrheal drugs - chronic treatment (product) |
agent antidiarrhéique |
| Antidiuretic hormone allergy |
Allergy to antidiuretic hormone |
| bas anti-embolie |
bas anti-thrombose |
| Antiestrogen |
Estrogen receptor antagonist |
| Antigen level |
Antigen assay |
| Antigen level (procedure) |
Antigen assay |
| Antigen level (procedure) |
Antigen assay |
| Antigen of Plasmodium (substance) |
Plasmodium antigen |
| Antigen of human leukocyte Cw10(w3) (substance) |
Human leukocyte antigen Cw10(w3) |
| Antigen of human leukocyte Cw9(w3) (substance) |
Human leucocyte antigen Cw9(w3) |
| Antigen test |
Antigen test |
| Antigen test |
Antigen test |
| Antigen-free surroundings |
Antigen-free surroundings |
| Lyme antigen |
Lyme antigen |
| Antihemophilic factor transfusion |
Antihaemophilic factor transfusion |
| Antihelminth drug prophylaxis |
Administration of prophylactic antihelminth (procedure) |
| Antihistamines (product) |
Product containing histamine receptor antagonist (product) |
| Antihypertensive overdose of undetermined intent |
Antihypertensive overdose |
| Antihypertensive therapy (procedure) |
Antihypertensive therapy |
| Antihypertensive therapy |
Antihypertensive therapy |
| Antilean piculet |
Nesoctites micromegas (organism) |